We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The FDA will commission the Institute of Medicine of the National Academies to evaluate the U.S. drug safety system and assess the FDA's role in delivering safe and effective drugs to the public, the agency announced November 7.